Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the...
from NDTV News - Latest https://ift.tt/3dKZIH5
No comments:
Post a Comment